INTRATHECAL ADMINISTRATION OF T REGULATORY CELLS IN THE TREATMENT OF MULTIPLE SCLEROSIS
Application
US20260083664A1
Kind: A1
Mar 26, 2026
Inventors
Piotr TRZONKOWSKI, Kamil CHWOJNICKI
Abstract
The invention relates to the medicinal product consisting of CD3+CD4+CD25+CD127− T regulatory cells administered intrathecally in the treatment of multiple sclerosis.
CPC Classifications
A61K 9/0019
A61K 40/11
A61K 40/22
A61K 40/416
A61P 25/00
C12N 5/0637
A61K 2239/31
Filing Date
2025-12-03
Application No.
19407506